MedTrace Logo

A Clinical Trial Evaluating a Total Disc Replacement in Patients With Cervical Disc Disease

NCT01433367 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2025-12-24

No results posted yet for this study

Summary

This study will be a non-randomized trial consisting of patients with single level (C3 to C7) symptomatic cervical disc disease who have not previously received fusion surgery at the same level, and have failed to improve with conservative treatment for at least 6 weeks prior to enrollment, or who present with progressive neurological symptoms or signs in the face of conservative treatment.

Conditions

  • Cervical Disc Disease

Interventions

DEVICE

CerPass® Total Disc Replacement

Single level cervical disc disease

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kelli Howell · NuVasive

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01433367 on ClinicalTrials.gov